Cerity Partners
AGN

Cerity Partners’s Allergan plc AGN Stock Holding History

Cerity Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,011
Closed -$1.17M – 598
2019
Q1 		$1.17M Sell
8,011
-5,181
-39% -$751K 0.08% 214
2018
Q4 		$1.76M Sell
13,192
-10,467
-44% -$1.72M 0.12% 169
2018
Q3 		$4.51M Buy
23,659
+1,675
+8% +$308K 0.31% 81
2018
Q2 		$3.67M Buy
21,984
+14,146
+180% +$2.27M 0.27% 98
2018
Q1 		$1.32M Buy
7,838
+2,394
+44% +$402K 0.1% 198
2017
Q4 		$890K Buy
5,444
+1,264
+30% +$227K 0.06% 252
2017
Q3 		$857K Buy
+4,180
New +$972K 0.06% 250
2017
Q2 		– Sell
-2,287
Closed -$546K – 456
2017
Q1 		$546K Buy
+2,287
New +$533K 0.05% 247

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cerity Partners's AGN Position: Q2 2019 in Review

Cerity Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 8,011 shares — an estimated $1.17M sold.

Cerity Partners first reported a position in AGN in Q1 2017 and held it in 8 quarters. The position peaked at $4.51M in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cerity Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cerity Partners sold 8,011 Allergan plc shares in Q2 2019, an estimated $1.17M.
  • Cerity Partners first reported a position in Allergan plc in Q1 2017 and held it in 8 quarters.
  • Cerity Partners's Allergan plc position peaked at $4.51M in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cerity Partners's 13F filing for Q2 2019, filed 14 Aug 2019.